Page last updated: 2024-09-05

lanperisone and bi 2536

lanperisone has been researched along with bi 2536 in 1 studies

Compound Research Comparison

Studies
(lanperisone)
Trials
(lanperisone)
Recent Studies (post-2010)
(lanperisone)
Studies
(bi 2536)
Trials
(bi 2536)
Recent Studies (post-2010) (bi 2536)
1101019313169

Protein Interaction Comparison

ProteinTaxonomylanperisone (IC50)bi 2536 (IC50)
Bromodomain-containing protein 4Homo sapiens (human)0.1211
Cytochrome P450 3A4Homo sapiens (human)0.0593
Transcription initiation factor TFIID subunit 1Homo sapiens (human)0.16
Serine/threonine-protein kinase PLK1Homo sapiens (human)0.0549
Bromodomain testis-specific proteinHomo sapiens (human)0.83
Serine/threonine-protein kinase PLK3Homo sapiens (human)0.0148
Serine/threonine-protein kinase PLK2Homo sapiens (human)0.0123
ALK tyrosine kinase receptorHomo sapiens (human)0.408

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frett, B; Kaiser, CE; Li, HY; Wang, Y1

Reviews

1 review(s) available for lanperisone and bi 2536

ArticleYear
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
    Journal of medicinal chemistry, 2013, Jul-11, Volume: 56, Issue:13

    Topics: Cell Cycle Proteins; Humans; Models, Biological; Molecular Structure; Molecular Targeted Therapy; Mutation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Signal Transduction; Small Molecule Libraries

2013